Viewing Study NCT07238569

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-05-29 @ 12:57 PM
Study NCT ID: NCT07238569
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-20
First Post: 2025-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nasopharyngeal Cancinoma (NPC) View
None Nasopharangeal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adebrelimab View
None PD-L1 antibody View
None chemoradiotherapy View
None capecitabine View